1. Establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of human papillomaviruses: guidance for Industry and Food and Drug Administration staff Publication: Silver Spring, MD : Center for Devices and Radiological Health, September 15, 2017 Subject(s): Device ApprovalPapillomavirus Infections -- diagnosisReagent Kits, Diagnostic -- standardsCervix Uteri -- cytologyCervix Uteri -- virologyEquipment FailureEquipment SafetyGenotyping Techniques -- standardsMass ScreeningPapillomaviridae -- classificationPapillomaviridae -- geneticsQuality ControlReference StandardsReproducibility of ResultsResearch DesignSpecimen HandlingHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 13, 2018 Subject(s): Genetic TestingGerm-Line MutationDiagnostic Test ApprovalReagent Kits, Diagnostic -- standardsSequence Analysis, DNAGenomicsReproducibility of ResultsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics: guidance for stakeholders and Food and Drug Administration staff Publication: Silver Spring, MD : Center for Devices and Radiological Health, April 13, 2018 Subject(s): Databases, GeneticReagent Kits, Diagnostic -- standardsReproducibility of ResultsAccess to InformationHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
4. Bioanalytical method validation Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018 Subject(s): Drug Evaluation, Preclinical -- standardsReproducibility of ResultsResearch Design -- standardsValidation Studies as TopicBiomarkersDocumentationDried Blood Spot Testing -- standardsInvestigational New Drug ApplicationQuality ControlReagent Kits, Diagnostic -- standardsSensitivity and SpecificitySpecimen Handling -- standardsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
5. Use of electronic health record data in clinical investigations Publication: Silver Spring, MD : Center for Drug Evaluation and Research, July 2018 Subject(s): Clinical Trials as TopicElectronic Health Records -- utilizationHealth Information InteroperabilityForms and Records ControlInformed ConsentReproducibility of ResultsSingle-Blind MethodHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
6. Elemental impurities in drug products Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2018 Subject(s): Chemistry, PharmaceuticalDrug ContaminationQuality ControlInternational CooperationInvestigational New Drug ApplicationReproducibility of ResultsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
7. Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 5, 2017 Subject(s): Computer-Aided Design -- standardsDevice ApprovalManufactured Materials -- standardsMaterials Testing -- standardsPrinting, Three-Dimensional -- standardsQuality ControlComputer Security -- standardsDiagnostic ImagingModels, AnatomicProduct Labeling -- standardsReproducibility of ResultsSoftware -- standardsSterilization -- standardsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
8. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff Publication: Silver Spring, MD : Center for Devices and Radiological Health, December 8, 2017 Subject(s): Equipment and Supplies -- standardsReproducibility of ResultsSoftware -- standardsInternational CooperationHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.